Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01253850 · ClinicalTrials.gov registry record
Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase I
A clinical trial, sponsored by Fenway Community Health.
- Completed
- Registry status
- 31
- Enrollment target
NCT01253850 is a clinical trial that has completed, run by Fenway Community Health. The registered enrollment target is 31 participants.
The verdict
NCT01253850 has completed, sponsored by Fenway Community Health.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
HIV is increasing among adolescents and young adults in the US. Antiretroviral medications, when taken correctly (≥90% of prescribed doses taken), can vastly improve life expectancy. However, adherence among HIV-infected young people is suboptimal, and few interventions are available to help adolescents adhere to treatment. The first phase of the study is an intervention development phase, which includes conducting interviews with 40 HIV-infected youth for input on the adaptation of the approach. The information obtained from the qualitative interviews is used to adapt the Life-Steps intervention (designed by our group for HIV-infected adults) to be responsive to the needs of HIV-infected adolescents, with acceptability of topics and content, and feasibility of intervention delivery to be tested in an open pilot trial.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-03-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01253850
The ClinicalTrials.gov registry entry for NCT01253850 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fenway Community Health, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01253850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01253850 about?
NCT01253850 is a clinical study titled "Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase I". HIV is increasing among adolescents and young adults in the US. Antiretroviral medications, when taken correctly (≥90% of prescribed doses taken), can vastly improve life expectancy. However, adherence among HIV-infected young people is suboptimal, and few interventions are available to help adolesc...
What is the current status of trial NCT01253850?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2010-08. Estimated completion is 2013-03-06.
Who is sponsoring clinical trial NCT01253850?
This trial is sponsored by Fenway Community Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.